EIF4A inhibitors (EIF4Ai), but not MTOR inhibitors, lead to specific translational reprogramming, which results in mitochondrial depolarization and cancer cell death (Gandin et al. 2016) (Fig. 2). This evidence concerns the gene EIF4A1 and cancer.